Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

INTRODUCTION: We used the data of the German biologics register RABBIT, a nationwide prospective cohort study, to investigate the risk of new or recurrent malignancy in patients with rheumatoid arthritis (RA) receiving biologics compared to conventional disease modifying anti-rheumatic drugs (DMARDs...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Strangfeld, Anja, Hierse, Franka, Rau, Rolf, Burmester, Gerd-Ruediger, Krummel-Lorenz, Brigitte, Demary, Winfried, Listing, Joachim, Zink, Angela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2010
Gaiak:
Research article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875631/
https://ncbi.nlm.nih.gov/pubmed/20064207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2904
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak